MYH3 and Feingold syndrome: Our study found that Tuina could reverse capsule fibrosis by promoting Myh3 phosphorylation at S1916, S1148, S949, and T379, which indicated that Myh3 phosphorylation plays a crucial role in the mechanism of the treatment of Tuina therapy in FS.